68.37
price up icon4.66%   3.40
after-market Handel nachbörslich: 68.37
loading
Schlusskurs vom Vortag:
$64.97
Offen:
$63.02
24-Stunden-Volumen:
145.48K
Relative Volume:
2.05
Marktkapitalisierung:
$481.60M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-4.98M
KGV:
-51.89
EPS:
-1.3177
Netto-Cashflow:
$-3.85M
1W Leistung:
+33.78%
1M Leistung:
+39.49%
6M Leistung:
+107.63%
1J Leistung:
+2,631%
1-Tages-Spanne:
Value
$57.00
$69.53
1-Wochen-Bereich:
Value
$49.84
$69.53
52-Wochen-Spanne:
Value
$2.47
$79.02

Bright Minds Biosciences Inc Stock (DRUG) Company Profile

Name
Firmenname
Bright Minds Biosciences Inc
Name
Telefon
-
Name
Adresse
-
Name
Mitarbeiter
0
Name
Twitter
Name
Nächster Verdiensttermin
Name
Neueste SEC-Einreichungen
Name
DRUG's Discussions on Twitter

Vergleichen Sie DRUG mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
DRUG
Bright Minds Biosciences Inc
68.37 460.55M 0 -4.98M -3.85M -1.3177
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
412.22 104.45B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
469.36 60.95B 2.46B -319.09M -52.09M -2.4669
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
572.60 59.11B 14.21B 4.46B 3.56B 39.69
Biotechnology icon
ARGX
Argen X Se Adr
812.95 49.23B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
ONC
Beone Medicines Ltd Adr
320.94 35.92B 4.56B -176.77M 225.30M -1.7177

Bright Minds Biosciences Inc Stock (DRUG) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-09-08 Eingeleitet BTIG Research Buy
2025-05-13 Eingeleitet TD Cowen Buy
2025-05-07 Eingeleitet Chardan Capital Markets Buy
2025-01-23 Eingeleitet Piper Sandler Overweight
2025-01-10 Eingeleitet Cantor Fitzgerald Overweight
2025-01-10 Eingeleitet H.C. Wainwright Buy
2024-11-26 Eingeleitet Robert W. Baird Outperform
Alle ansehen

Bright Minds Biosciences Inc Aktie (DRUG) Neueste Nachrichten

pulisher
07:04 AM

Has Bright Minds Biosciences Inc. found a price floorGlobal Markets & Short-Term High Return Ideas - newser.com

07:04 AM
pulisher
06:13 AM

Exit strategy if you’re trapped in Bright Minds Biosciences Inc.July 2025 Retail & Weekly Momentum Picks - newser.com

06:13 AM
pulisher
05:45 AM

Risk vs reward if holding onto Bright Minds Biosciences Inc.Weekly Profit Summary & AI Driven Stock Price Forecasts - newser.com

05:45 AM
pulisher
04:42 AM

Will Bright Minds Biosciences Inc. outperform the marketInflation Watch & Weekly Top Stock Performers List - newser.com

04:42 AM
pulisher
Oct 13, 2025

Visualizing Bright Minds Biosciences Inc. stock with heatmaps2025 Trade Ideas & Fast Gain Stock Tips - newser.com

Oct 13, 2025
pulisher
Oct 13, 2025

Published on: 2025-10-13 07:44:40 - newser.com

Oct 13, 2025
pulisher
Oct 11, 2025

Insiders Who Sold CA$17m Of Bright Minds Biosciences Made The Right Call - simplywall.st

Oct 11, 2025
pulisher
Oct 10, 2025

Published on: 2025-10-10 09:53:23 - newser.com

Oct 10, 2025
pulisher
Oct 10, 2025

How to use Fibonacci retracement on Bright Minds Biosciences Inc.July 2025 WrapUp & AI Enhanced Trading Alerts - newser.com

Oct 10, 2025
pulisher
Oct 09, 2025

What technical models suggest about Bright Minds Biosciences Inc.’s comebackQuarterly Earnings Summary & Reliable Intraday Trade Alerts - newser.com

Oct 09, 2025
pulisher
Oct 09, 2025

Regression analysis insights on Bright Minds Biosciences Inc. performanceMarket Performance Summary & AI Powered Market Entry Ideas - newser.com

Oct 09, 2025
pulisher
Oct 09, 2025

Published on: 2025-10-09 04:28:20 - newser.com

Oct 09, 2025
pulisher
Oct 07, 2025

Bright Minds Biosciences Inc. (NASDAQ:DRUG) Receives $81.00 Consensus Target Price from Analysts - Defense World

Oct 07, 2025
pulisher
Oct 05, 2025

Bright Minds Biosciences (NASDAQ:DRUG) Stock Rating Lowered by Wall Street Zen - Defense World

Oct 05, 2025
pulisher
Oct 04, 2025

Bright Minds Biosciences Inc. (NASDAQ:DRUG) Receives Average Rating of "Buy" from Analysts - MarketBeat

Oct 04, 2025
pulisher
Oct 04, 2025

Bright Minds Biosciences (NASDAQ:DRUG) Cut to Sell at Wall Street Zen - MarketBeat

Oct 04, 2025
pulisher
Oct 03, 2025

Will Bright Minds Biosciences Inc. stock outperform growth indexesJuly 2025 Pullbacks & Daily Market Momentum Tracking - newser.com

Oct 03, 2025
pulisher
Oct 02, 2025

BTIG Maintains Bright Minds Biosciences(DRUG.US) With Buy Rating, Maintains Target Price $72 - 富途牛牛

Oct 02, 2025
pulisher
Sep 30, 2025

Published on: 2025-09-30 11:54:24 - earlytimes.in

Sep 30, 2025
pulisher
Sep 28, 2025

What analysts say about Bright Minds Biosciences Inc stockResistance Zone Identification & High Return Investment Plans - earlytimes.in

Sep 28, 2025
pulisher
Sep 28, 2025

Is Bright Minds Biosciences Inc a good long term investmentMarket Liquidity Analysis & Explosive Capital Growth Plans - earlytimes.in

Sep 28, 2025
pulisher
Sep 27, 2025

What drives Bright Minds Biosciences Inc stock priceAI-Driven Market Analysis & Low Risk Investment Growth - earlytimes.in

Sep 27, 2025
pulisher
Sep 26, 2025

Bright Minds Biosciences Inc Stock Analysis and ForecastCandlestick Pattern Analysis & Fast Profit Stock Ideas - Early Times

Sep 26, 2025
pulisher
Sep 25, 2025

H.C. Wainwright Maintains Bright Minds Biosciences(DRUG.US) With Buy Rating, Maintains Target Price $85 - 富途牛牛

Sep 25, 2025
pulisher
Sep 24, 2025

Goldman Sachs Group Inc. Takes Position in Bright Minds Biosciences Inc. $DRUG - Defense World

Sep 24, 2025
pulisher
Sep 23, 2025

Bright Minds Biosciences (NASDAQ:DRUG) Rating Increased to Hold at Wall Street Zen - MarketBeat

Sep 23, 2025
pulisher
Sep 22, 2025

Relative strength of Bright Minds Biosciences Inc. in sector analysisProduct Launch & Stepwise Entry/Exit Trade Alerts - newser.com

Sep 22, 2025
pulisher
Sep 20, 2025

Using data filters to optimize entry into Bright Minds Biosciences Inc.July 2025 Gainers & Precise Buy Zone Identification - newser.com

Sep 20, 2025
pulisher
Sep 20, 2025

Bright Minds Biosciences (NASDAQ:DRUG) Upgraded by Wall Street Zen to Hold Rating - Defense World

Sep 20, 2025
pulisher
Sep 19, 2025

Chart based analysis of Bright Minds Biosciences Inc. trendsEarnings Trend Report & High Accuracy Trade Alerts - newser.com

Sep 19, 2025
pulisher
Sep 19, 2025

Portfolio Update: How is Bright Minds Biosciences Inc managing supply chain issues2025 Winners & Losers & Free High Return Stock Watch Alerts - khodrobank.com

Sep 19, 2025
pulisher
Sep 19, 2025

How to forecast Bright Minds Biosciences Inc. trends using time seriesOptions Play & Fast Gain Stock Trading Tips - newser.com

Sep 19, 2025
pulisher
Sep 19, 2025

What data driven models say about Bright Minds Biosciences Inc.’s futureMarket Performance Report & Verified Short-Term Trading Plans - newser.com

Sep 19, 2025
pulisher
Sep 19, 2025

HC Wainwright Reaffirms "Buy" Rating for Bright Minds Biosciences (NASDAQ:DRUG) - MarketBeat

Sep 19, 2025
pulisher
Sep 19, 2025

Aug Sectors: What is HIPOs 5 year growth outlookEarnings Performance Report & Technical Pattern Based Signals - khodrobank.com

Sep 19, 2025
pulisher
Sep 19, 2025

S P Trends: What is Bright Minds Biosciences Inc. s revenue forecast2025 Biggest Moves & Precise Buy Zone Tips - خودرو بانک

Sep 19, 2025
pulisher
Sep 18, 2025

Wall Street Analysts Believe Bright Minds Biosciences Inc. (DRUG) Could Rally 81.29%: Here's is How to Trade - Yahoo Finance

Sep 18, 2025
pulisher
Sep 18, 2025

Bright Minds Biosciences Reports Q3 2025 Financial Results - MSN

Sep 18, 2025
pulisher
Sep 17, 2025

Growth Report: Is Driven Brands Holdings Inc. undervalued by DCF analysisJuly 2025 Weekly Recap & High Conviction Trade Alerts - خودرو بانک

Sep 17, 2025
pulisher
Sep 17, 2025

Bright Minds rebounds after $35M private placement - MSN

Sep 17, 2025

Finanzdaten der Bright Minds Biosciences Inc-Aktie (DRUG)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading

Bright Minds Biosciences Inc-Aktie (DRUG) Insiderhandel

Insiderhandel Beziehung Datum Transaktion Kosten #Aktien Wert ($) #Aktien Gesamt
Cormorant Asset Management, LP
10% Owner
Oct 15 '24
Buy
5.53
372,591
2,061,574
825,000
Cormorant Asset Management, LP
10% Owner
Oct 16 '24
Buy
23.46
50,000
1,172,813
875,000
$21.75
price down icon 5.47%
$85.96
price up icon 1.59%
$32.75
price up icon 0.41%
$102.61
price up icon 0.29%
$161.38
price down icon 1.45%
biotechnology ONC
$320.94
price down icon 1.85%
Kapitalisierung:     |  Volumen (24h):